Capital World Investors
Position in CRL — Charles River Laboratories International, Inc.
CIK 1422849
LOS ANGELES, CA
Position in CRL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,405,702
New position
Shares Held
8,149
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Capital World Investors holds $5,982,795,766 across 7 Diagnostics & Research names. CRL ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,646,316 | $3,266,863,703 | |
| 2 | ILMN |
Illumina, Inc.
|
15,549,960 | $1,916,688,069 | |
| 3 | NTRA |
Natera, Inc.
|
1,467,975 | $293,580,320 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
497,851 | $279,737,498 | |
| 5 | ICLR |
Icon PLC
|
1,104,831 | $122,260,598 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
599,624 | $102,259,876 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
This page
|
8,149 | $1,405,702 |
All Filings in CRL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,405,702 | 8,149 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||